EMERGENCY USE AUTHORIZATION (EUA) OF THE JANSSEN COVID-19 VACCINE TO PREVENT CORONAVIRUS DISEASE 2019 (COVID-19) IN INDIVIDUALS 18 YEARS OF AGE AND OLDER : https://www.fda.gov
EMERGENCY USE AUTHORIZATION (EUA) OFTHE PFIZER-BIONTECH COVID-19 VACCINE TO PREVENT CORONAVIRUS DISEASE 2019 (COVID-19) :
https://www.fda.gov
FACT SHEET FOR RECIPIENTS AND CAREGIVERSEMERGENCY USE AUTHORIZATION (EUA) OF THE MODERNA COVID-19 VACCINE TO PREVENT CORONAVIRUS DISEASE 2019 (COVID-19) IN INDIVIDUALS 18 YEARS OF AGE AND OLDER :
https://www.fda.gov
Données COVID-19 par âge et sexe au Québec
https://www.inspq.qc.ca
Benefits of Getting a COVID-19 Vaccine
he Vaccine Adverse Event Reporting System (VAERS)
https://wonder.cdc.gov
Maladie à coronavirus (COVID-19) : Prévention et risques
https://www.canada.ca/fr/sante-publique
Le consentement : Guide à l'intention des médecins du Canada
Fiche de synthèse : différentes technologies vaccinales anti-covid
8 - L'article 21 du Code civil du Québec et la recherche : présent et futur
https://www.acfas.ca
Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals
https://clinicaltrials.gov